Relay Therapeutics, Inc. · NASDAQ:RLAY
Catinazzo Thomas sold 17,717 Relay Therapeutics, Inc. shares (Form 4)
Traded Oct 6, 2026 · Filed Oct 8, 2026
On Oct 6, 2026, Catinazzo Thomas (Chief Financial Officer) sold 17,717 Relay Therapeutics, Inc. shares at an average US$18.59 for US$329K under a trading plan, leaving 105,134 shares. Filed Oct 8, 2026 (Form 4).
- Sold
- 17,717 shares
- Price
- US$18.59 average (US$18.58 to US$19.26)
- Value
- US$329K
- Holding after
- 105,134 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Common Stock | Sale | 17,511 | US$18.58 | 105,340 | Direct |
| Oct 6, 2026 | Common Stock | Sale | 206 | US$19.26 | 105,134 | Direct |
Source
Related
- Relay Therapeutics, Inc.
- Catinazzo Thomas
- Relay Therapeutics, Inc. shareholders
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Aug 18, 2026
- Form 4 · Catinazzo Thomas · Jul 30, 2026
- Form 4 · Catinazzo Thomas · Jul 8, 2026
- Form 4 · Catinazzo Thomas · Jun 24, 2026
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026
- Form 4 · Rahmer Peter · Aug 28, 2026
- Form 4 · Sb Investment Advisers (UK) LTD · Aug 28, 2026